ARTICLES BY THIS AUTHOR

• 6/29/2010

  Ont. job action policy update happening at interesting time

• 6/29/2010

  Ontario pharmacies get some, not all, details on generic pricing

• 6/29/2010

  BC's nurse practitioners want in on healthcare talks

• 6/29/2010

  Is your investment just sitting there?

  How do you make a small fortune in this industry? By maximizing the return on the investment you have in your business.
• 6/29/2010

  Quebec cuts could have 'heavy consequences': CGPA

• 6/29/2010

  Connecting with readers at OPA conference

• 6/29/2010

  Mirena approved for heavy menstrual bleeding

• 6/29/2010

  The father of rehab nursing

  You can hear the pride in his voice when Daniel Savoie confesses that colleagues sometimes refer to him as the father of rehabilitation nursing in Canada.
• 6/29/2010

  Walmart Canada raises $5.4 m for children's hospitals

• 6/29/2010

  Ask the Experts: Issues in switching to generic antidepressants

  Question: I am a clinical epidemiologist taking an initial look at generics vs. brand drugs for depression. There are some concerns in the published literature regarding determining the requirements for bio-equivalence of "highly-variable" (HV) drugs.